10 Year's Expreience on Gestational Trophoblastic Disease.
- Author:
Eun Hee CHYU
;
Gun Sang YOO
;
Won Gue KIM
;
Un Dong PARK
- Publication Type:Original Article
- Keywords:
10 year;
gestational trophoblastic disease
- MeSH:
Busan;
Choriocarcinoma;
Dilatation and Curettage;
Drug Therapy;
Female;
Gestational Trophoblastic Disease*;
Gynecology;
Humans;
Hydatidiform Mole;
Hydatidiform Mole, Invasive;
Incidence;
Korea;
Obstetrics;
Pregnancy;
Retrospective Studies;
Trophoblasts;
Uterine Hemorrhage
- From:Korean Journal of Gynecologic Oncology and Colposcopy
1996;7(2):84-92
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
For the clinical analysis and evaluation on the patients with gestational trophoblastic disease(GTD), a study was done retrospectively on 114 patients with GTD(60 in Hydatidiform mole, 10 in invasive mole, 44 in choriocarcinoma) treated from Jan. 1, 1985 to Dec. 31, 1994 at the Department of Obstetrics and Gynecology, Kosin Medical College, Pusan, Korea. We obtained the following results ; The incidence of GTD was 1 per 73 deliveries in H. mole, 1 per 437 deliveries in invasive mole, and 1 per 99 deliveries in choriocarcinoma. The most prevalent age was 21-40 groups. Abnormal vaginal bleeding was a main symptom and sign. 30.6% of H. mole was managed by dilatation and curettage. 90.0% of invasive mole and 51.4% of choriocarcinoma were managed by surgical treatment and chemotherapy. The overall remissinon rate of choriocarcinoma was 71.4%(100.0% in stage I, 66.7% in stage II, 54.5% in stage III, 50.0% in stage IV).
